ArticleBiomaterials research2026
Bioactive Mineralized Cell-Derived Extracellular Matrix via Polymer-Induced Liquid Precursor Enhances Osteogenesis and Bone Regeneration.
Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective bone regeneration requires biomaterials that exhibit appropriate bioactive functions, particularly osteoconductive and osteoinductive properties. Here, we engineered a cell-derived, decellularized extracellular matrix (cdECM) into a novel mineralized ECM scaffold by harnessing the polymer-induced liquid precursor (PILP) process, an effective strategy for generating calcium phosphate (CaP) mineralized constructs. Mineral deposition within cdECM was successfully achieved through the PILP mineralization, which stabilizes the amorphous precursor phase and promotes matrix-associated mineralization. The resulting mineralized ECM (mECM) exhibited osteoconductive properties, as evidenced by excellent cytocompatibility and enhanced cell proliferation of osteogenic cells. The mECM also demonstrated osteoinductive potential, as confirmed by enhanced alkaline phosphatase activity, increased calcification, and up-regulated osteogenic gene expression in mouse preosteoblasts and human mesenchymal stem cells. Moreover, mECM promoted M2-like macrophage polarization and enhanced tubular formation of endothelial cells. To enable localized in vivo delivery of both ECM-derived biological cues and minerals, a sheet-type mECM scaffold was fabricated using hyaluronic acid as a supporting matrix and further stabilized by glutaraldehyde vapor crosslinking. In a mouse calvarial defect model, the mECM sheet facilitated new bone formation and supported advanced bone maturation, accompanied by enhanced angiogenesis and an M2-dominant anti-inflammatory milieu at an early time point. Collectively, our findings demonstrate that PILP mineralization can be successfully applied to cdECM for generating a bioactive mECM scaffold with enhanced regenerative capacity, representing a promising biomaterial platform for bone tissue regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.